Healthcare provider profile · identity verified

Simran Kaur Bhandari, M.D.

Internal Medicine · LOS ANGELES, CA · NPI 1639313299

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	778	480
Amlodipine Besylate	Amlodipine Besylate	470	299
Lisinopril	Lisinopril	413	254
Losartan Potassium	Losartan Potassium	344	230
Metformin Hcl	Metformin Hcl	330	218
Levothyroxine Sodium	Levothyroxine Sodium	294	175
Omeprazole	Omeprazole	270	179
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	262	153
Glipizide	Glipizide	229	147
Metoprolol Tartrate	Metoprolol Tartrate	224	117
Rosuvastatin Calcium	Rosuvastatin Calcium	213	143
Albuterol Sulfate Hfa	Albuterol Sulfate	209	160
Hydrochlorothiazide	Hydrochlorothiazide	205	124
Simvastatin	Simvastatin	187	115
Meloxicam	Meloxicam	186	126
Atenolol	Atenolol	180	119
Ibuprofen	Ibuprofen	179	110
Gabapentin	Gabapentin	169	111
Jardiance	Empagliflozin	157	77
Furosemide	Furosemide	151	101
Potassium Chloride	Potassium Chloride	144	101
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	137	86
Ozempic	Semaglutide	132	57
Alendronate Sodium	Alendronate Sodium	131	79
Bisoprolol Fumarate	Bisoprolol Fumarate	127	70
Metformin Hcl Er	Metformin Hcl	123	83
Lorazepam	Lorazepam	116	62
Pantoprazole Sodium	Pantoprazole Sodium	111	65
Tamsulosin Hcl	Tamsulosin Hcl	98	62
Hydralazine Hcl	Hydralazine Hcl	92	62
Pradaxa	Dabigatran Etexilate Mesylate	85	55
Allopurinol	Allopurinol	81	52
Triamcinolone Acetonide	Triamcinolone Acetonide	74	51
Tramadol Hcl	Tramadol Hcl	67	49
Lactulose	Lactulose	66	34
Temazepam	Temazepam	66	23
Clopidogrel	Clopidogrel Bisulfate	64	42
Finasteride	Finasteride	64	37
Alprazolam	Alprazolam	62	30
Humulin N	Insulin Nph Human Isophane	62	37
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	62	37
Famotidine	Famotidine	56	37
Spironolactone	Spironolactone	56	41
Trazodone Hcl	Trazodone Hcl	54	39
Carvedilol	Carvedilol	53	35
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	50	36
Spiriva Respimat	Tiotropium Bromide	47	23
Pravastatin Sodium	Pravastatin Sodium	46	29
Acetaminophen-Codeine	Acetaminophen With Codeine	45	30
Mirtazapine	Mirtazapine	44	21
Wixela Inhub	Fluticasone Propion/Salmeterol	42	31
Eliquis	Apixaban	41	30
Humulin N Kwikpen	Insulin Nph Human Isophane	40	27
Prednisone	Prednisone	40	28
Humulin R	Insulin Regular, Human	38	30
Montelukast Sodium	Montelukast Sodium	38	25
Buspirone Hcl	Buspirone Hcl	36	16
Hydrocortisone	Hydrocortisone	36	25
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	36	23
Sertraline Hcl	Sertraline Hcl	36	24
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	36	23
Duloxetine Hcl	Duloxetine Hcl	35	27
Naproxen	Naproxen	35	25
Ondansetron Odt	Ondansetron	35	23
Terazosin Hcl	Terazosin Hcl	35	28
Acyclovir	Acyclovir	34	21
Escitalopram Oxalate	Escitalopram Oxalate	34	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	27
Lovastatin	Lovastatin	32	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	30
Azithromycin	Azithromycin	30	29
Pioglitazone Hcl	Pioglitazone Hcl	30	20
Fluticasone Propionate	Fluticasone Propionate	29	24
Pregabalin	Pregabalin	29	18
Azelastine Hcl	Azelastine Hcl	28	20
Colchicine	Colchicine	28	20
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Benazepril Hcl	Benazepril Hcl	27	16
Fluconazole	Fluconazole	26	21
Propranolol Hcl	Propranolol Hcl	25	13
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	24	15
Fluoxetine Hcl	Fluoxetine Hcl	23	12
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	18
Xarelto	Rivaroxaban	22	suppressed
Baclofen	Baclofen	21	13
Clobetasol Propionate	Clobetasol Propionate	21	17
Ezetimibe	Ezetimibe	21	13
Nortriptyline Hcl	Nortriptyline Hcl	21	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Cephalexin	Cephalexin	20	19
Victoza 2-Pak	Liraglutide	20	12
Ciclopirox	Ciclopirox	19	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	16
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Ketoconazole	Ketoconazole	18	13
Mupirocin	Mupirocin	18	12
Nifedipine Er	Nifedipine	18	15
Nitroglycerin	Nitroglycerin	18	14
Ondansetron Hcl	Ondansetron Hcl	18	12
Trospium Chloride	Trospium Chloride	18	suppressed
Victoza 3-Pak	Liraglutide	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Glipizide Er	Glipizide	17	13
Liraglutide	Liraglutide	17	11
Warfarin Sodium	Warfarin Sodium	17	12
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nystatin	Nystatin	16	13
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Amoxicillin	Amoxicillin	15	15
Fluocinonide	Fluocinonide	15	11
Metronidazole	Metronidazole	15	15
Acarbose	Acarbose	14	suppressed
Alvesco	Ciclesonide	14	12
Chlorthalidone	Chlorthalidone	14	11
Citalopram Hbr	Citalopram Hydrobromide	14	11
Clonidine Hcl	Clonidine Hcl	14	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	12
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Metoprolol Succinate	Metoprolol Succinate	12	12
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	11
Digoxin	Digoxin	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Scopolamine	Scopolamine	11	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error